Genetic Polymorphisms and Disease

  • Altshuler D
  • Kruglyak L
  • Lander E
100Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Genetic causes of individual variation in drug response can be divided into two categories. First, conditions characterized by abnormal metabolism of drugs by the body. Second, conditions in which drugs or metabolites act abnormally on the body due to genetically altered receptor sites. Genetic polymorphism of drug metabolizing enzymes gives rise to distinct subgroups in the population that differ in their ability to perform a certain drug biotransformation reaction. Individuals with deficient metabolism of certain drugs are called Poor Metabolizers or PM Phenotypes as compared to these ones which are called Normal Extensive Metabolizers or EM Phenotypes.

Cited by Powered by Scopus

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

1663Citations
N/AReaders
Get full text

A comprehensive review of genetic association studies

1432Citations
N/AReaders
Get full text

Problems of reporting genetic associations with complex outcomes

1035Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Altshuler, D., Kruglyak, L., & Lander, E. (1998). Genetic Polymorphisms and Disease. New England Journal of Medicine, 338(22), 1626–1626. https://doi.org/10.1056/nejm199805283382214

Readers over time

‘11‘12‘13‘14‘15‘16‘17‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

Researcher 8

40%

PhD / Post grad / Masters / Doc 7

35%

Professor / Associate Prof. 5

25%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

37%

Biochemistry, Genetics and Molecular Bi... 6

32%

Medicine and Dentistry 4

21%

Immunology and Microbiology 2

11%

Save time finding and organizing research with Mendeley

Sign up for free
0